Saroja Pharma Industries India Limited — Others, 20-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Saroja Pharma Industries India Limited submits a confirmation certificate to the National Stock Exchange, complying with SEBI regulations regarding the dematerialization and rematerialization of securities for the quarter ended December 31, 2024. This certificate, issued by KFIN Technologies, affirms that all necessary details have been communicated to the relevant stock exchanges.

While this announcement reflects adherence to regulatory compliance, it does not indicate any immediate operational shifts. Investors may perceive this as a neutral impact, reinforcing the company’s commitment to transparency without signaling substantial changes that could alter their investment thesis.